secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2022-06-03T23:59:59+00:00
Accession:  0001842952-22-000050
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics shareholders ratify CohnReznick as auditor for FY 2022
---------------------------------------------------------------------------

- Annual meeting held June 2, 2022; quorum of 9,161,941 shares (57.38%) present.
- Proposal 1: Ratification of CohnReznick LLP as independent auditor for 2022.
- Votes: 9,144,524 For, 8,877 Against, 8,540 Abstentions; no broker non-votes.
- Auditor appointment for year ending December 31, 2022 approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000184295222000050/0001842952-22-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000184295222000050/cntx-20220602.htm
  HTML page:      https://secwatch.observer/filing/0001842952-22-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer